Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study

Objective: To evaluate the efficacy and safety of dasotraline for treatment of ADHD in children. Method: Children (ages 6-12 years; N = 112) with ADHD were randomized, double-blind, to 14 days of once-daily evening doses of dasotraline 4 mg or placebo. ADHD symptom severity was measured at baseline...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigal, Sharon B., Hopkins, Seth C., Koblan, Kenneth S., Childress, Ann, Kent, Justine M., Tsai, Joyce, Hsu, Jay, Loebel, Antony, Goldman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Current Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129465/
https://www.ncbi.nlm.nih.gov/pubmed/31375051
http://dx.doi.org/10.1177/1087054719864644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129465/
https://www.ncbi.nlm.nih.gov/pubmed/31375051
http://dx.doi.org/10.1177/1087054719864644

Ejemplares similares